Female genital neoplasms

PubMed Free Full Text

Cervical cancer: vaccine

Africa

• Human Vaccines & Immunotherapeutics
  • Exploring the complexity of the implementation determinants of human papillomavirus vaccination in Africa through a systems thinking lens: A rapid review [2024]

Africa, Asia

• Asian Pacific Journal of Cancer Prevention
  • Racial Disparities Associated with the Prevalence of Vaccine and Non-Vaccine HPV Types and Multiple HPV Infections between Asia and Africa: A Systematic Review and Meta-Analysis [2021]

Americas

• Pan American Health Organization
  • Tag Recommendations for Human Papilloma Virus (HPV) [2024]
  • Methodology to calculate HPV Vaccine Coverage in the Region of the Americas [2019]
  • Human Papillomavirus (HPV) Vaccine

Asia-Pacific

• Asia and Oceania Federation of Obstetrics and Gynaecology
  • The AOFOG recommendations on human papillomavirus vaccination in the Asia-Pacific region [2024]

• Human Vaccines & Immunotherapeutics
  • Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region [2024]

Australia

• Australian Institute of Health and Welfare
  • HPV immunisation rates 2015–16 [2018]

• Australian Journal of General Practice
  • Human papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule [2018]

• Cancer Council
  • HPV Vaccine

• Department of Health, Disability and Ageing
  • HPV vaccine – Fact sheet outlining changes under the National Immunisation Program in 2023 [2023]
  • Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia [2020]
  • Human papillomavirus (HPV) | The Australian Immunisation Handbook

• EuroSurveillance
  • The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? [2018]

• Lancet Public Health
  • Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis [2016]

• PLoS ONE
  • Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia [2018]

Australia, New Zealand

• Royal Australian and New Zealand College of Obstetricians and Gynaecologists
  • Guidelines for Human Papillomavirus (HPV) Vaccine [2019]

Austria

• BMC Infectious Diseases
  • Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria [2016]

Bangladesh

• PLoS ONE
  • Acceptance of Human Papillomavirus (HPV) vaccine among the parents of eligible daughters (9-15 years) in Bangladesh: A nationwide study using Health Belief Model [2024]

Brazil

• Revista Latino-Americana de Enfermagem
  • Vaccination against human papillomavirus in Brazilian schoolchildren: National Survey of School Health, 2019 [2022]

Canada

• BMC Infectious Diseases
  • Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis [2011]

• Canadian Family Physician
  • Effect of human papillomavirus vaccination on sexual behaviour among young females [2018]
  • Update on the new 9-valent vaccine for human papillomavirus prevention [2016]
  • HPV vaccine for cancer and wart prevention [2015]

• Canadian Paediatric Society
  • Human papillomavirus vaccine for children and adolescents [2018]

• Human Vaccines & Immunotherapeutics
  • Estimates and determinants of HPV non-vaccination in 14-year-old Canadians: Results from the childhood national immunization coverage survey, 2019 [2024]
  • Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review [2023]

• Perinatal Services BC
  • HPV Immunization Series

• Public Health Agency of Canada
  • Updated recommendations on human papillomavirus vaccines [2024]
  • Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on human papillomavirus (HPV) vaccines [2024]
  • Human papillomavirus (HPV) vaccines: Canadian Immunization Guide

• Public Health Ontario
  • Recommendations for an Expanded Human Papillomavirus Immunization Program [2025]

Caribbean

• Pan American Health Organization
  • HPV Vaccination: Toward the Elimination of Cervical Cancer in the Caribbean Countries. Virtual Meeting Report, 22–23 and 29–30 October 2020 [2021]

Chile

• BMC Public Health
  • Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model [2014]

China

• BMC Health Services Research
  • Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey [2022]

• BMC Infectious Diseases
  • Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China [2017]

• BMC Public Health
  • Human papillomavirus vaccination at the national and provincial levels in China: a cost-effectiveness analysis using the PRIME model [2022]
  • Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies [2016]

• European Journal of Cancer Care
  • Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature [2022]

• Expert Review of Vaccines
  • Cost-effectiveness of human papillomavirus vaccination among girls aged 9-16 years in China: a meta-analysis [2025]

• Frontiers in Public Health
  • Frequency of health care provider recommendations for HPV vaccination: a survey in three large cities in China [2023]
  • A national cross-sectional study on the influencing factors of low HPV vaccination coverage in mainland China [2023]

• Human Vaccines & Immunotherapeutics
  • Parental willingness of HPV vaccination in Mainland China: A meta-analysis [2024]
  • Opportunities and challenges for human papillomavirus vaccination in China [2024]
  • Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women [2021]

• International Journal of Environmental Research and Public Health
  • HPV Vaccination Intentions of Female Students in Chinese Universities: A Systematic Literature Review and Meta-Analysis [2022]

• Preventive Medicine
  • A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in China [2021]

Costa Rica

• Journal of the National Cancer Institute
  • Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial [2023]

• Lancet Oncology
  • Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial [2022]

Cyprus

• BMC Women's Health
  • An analysis of the knowledge of adults aged between 18 and 45 on HPV along with their attitudes and beliefs about HPV vaccine: the Cyprus case [2023]

Czech Republic

• BMC Public Health
  • Burden of HPV-induced diseases and cost effectiveness of catch-up vaccination in Czech Republic: a model-based study [2025]

Denmark

• Acta Obstetricia et Gynecologica Scandinavica
  • High-grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study [2020]

• International Journal of Cancer
  • Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi-cohort vaccination against human papillomavirus infection [2023]
  • Prevalence of high-risk human papillomavirus after HPV-vaccination in Denmark [2020]

• Vaccine
  • Comparing Risk Behaviour among 14,614 Human Papillomavirus Vaccinated and Unvaccinated Danish Young Women [2025]

Developing countries

• Infectious Diseases in Obstetrics and Gynecology
  • Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries [2011]

Estonia

• BMC Infectious Diseases
  • The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia [2013]

Ethiopia

• BMC Public Health
  • Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis [2023]

• BMC Women's Health
  • Knowledge, attitude, and uptake of human papillomavirus vaccine among adolescent schoolgirls in Ethiopia: a systematic review and meta-analysis [2023]

• Frontiers in Public Health
  • A call for switching to a 1-dose 9vHPV national vaccination program in Ethiopia [2023]

• PLoS ONE
  • Human Papillomavirus Vaccination uptake and associated factors among schools girls aged between 9-14 years in Ethiopia: Performance Monitoring for Action (PMA-ET) 2023, multilevel analysis [2025]

Europe

• BMC Public Health
  • The structural and organizational aspects of human papillomavirus vaccine affecting immunization coverage in Europe: a systematic review [2025]

• Cancer Medicine
  • HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level [2019]

• European Centre for Disease Prevention and Control
  • Efficacy, effectiveness and safety of HPV vaccination in women with conisation: a systematic review and meta-analyses [2024]
  • Vaccine Scheduler - Human Papillomavirus Infection
  • Human papillomavirus

• European Commission
  • HPV

• European Society of Gynaecological Oncology
  • Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion [2025]
  • Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy [2019]

• EuroSurveillance
  • Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma [2021]

• Expert Review of Vaccines
  • Estimating the time required to reach HPV vaccination targets across Europe [2025]

• WHO European Region
  • Questions and answers about human papillomavirus, second edition [2024]
  • Communicating with caregivers about the Human Papillomavirus vaccination: facilitator’s guide [2023]
  • Communicating with caregivers about the Human Papillomavirus vaccination: a tool to build confidence in communication skills among health workers [2023]

Fiji

• BMC Public Health
  • Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents [2015]

France

• EuroSurveillance
  • Can physicians and schools mitigate social inequalities in human papillomavirus vaccine awareness, uptake and vaccination intention among adolescents? A cross-sectional study, France, 2021 to 2022 [2023]

• Human Vaccines & Immunotherapeutics
  • Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history [2015]
  • A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France [2013]

Germany

• Archives of Gynecology and Obstetrics
  • The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances [2024]

• Deutsches Ärzteblatt International
  • Initial Evidence of a Possible Effect of HPV Vaccination on Cancer Incidence in Germany—Focus on Cervical Cancer [2024]

• Frontiers in Public Health
  • Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study [2023]

Greece

• In Vivo
  • Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study [2020]

Gulf Cooperation Council

• Medicine
  • Parental Perspectives on Human Papillomavirus (HPV) Vaccination in Gulf Cooperation Council Countries: A systematic review [2024]

High-income countries

• BMC Public Health
  • Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis [2014]

• Expert Review of Vaccines
  • A review of data systems for assessing the impact of HPV vaccination in selected high-income countries [2023]

• Gynecologic Oncology
  • Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies [2025]

• Journal of Epidemiology and Community Health
  • Are there any sociodemographic factors associated with non-uptake of HPV vaccination of girls in high-income countries with school-based vaccination programmes? A systematic review [2025]

• Lancet
  • Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis [2019]

Hong Kong

• PLoS ONE
  • Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents [2018]

India

• Asian Pacific Journal of Cancer Prevention
  • Methodological Assessment of a Review of Knowledge, Attitude and Practice about Human Papilloma Virus Vaccination in India [2024]
  • Evidence of Knowledge, Attitude, and Practice Regarding Human Papilloma Virus Vaccination at the Community Level in India: A Systematic Review and Meta-analysis [2024]
  • HPV Vaccination of Girl Child in India: Intervention for Primary Prevention of Cervical Cancer [2018]

• Cancer Control
  • Gender-Neutral HPV Vaccine in India; Requisite for a Healthy Community: A Review [2024]

• Federation of Obstetric and Gynecological Societies of India
  • A Guide Book for Master Trainers: Preventing Cervical Cancer through HPV Vaccination in India [2024]

• Ministry of Health and Family Welfare India
  • Operational Guidelines for HPV Vaccine Introduction in India [2023]

Indonesia

• Asian Pacific Journal of Cancer Prevention
  • HPV Vaccination Program in Indonesia: Effectiveness, Dose, Scale-Up Costs, Future Prospects, and Policy Recommendations [2025]

• PLoS ONE
  • Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis [2020]

International

• Acta Obstetricia et Gynecologica Scandinavica
  • Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?-An updated systematic review and meta-analysis based on timing of vaccination [2024]

• BMC Infectious Diseases
  • Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis [2025]

• BMC Public Health
  • A systematic review of interventions to promote HPV vaccination globally [2023]

• BMC Women's Health
  • HPV vaccination, screening disparities, and the shifting landscape of cervical cancer burden: a global analysis of trends, inequalities, and policy implications [2025]
  • Global parental acceptance, attitudes, and knowledge regarding human papillomavirus vaccinations for their children: a systematic literature review and meta-analysis [2024]

• Cochrane Database of Systematic Reviews
  • Factors that influence caregivers' and adolescents' views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis [2025]

• European Review for Medical and Pharmacological Sciences
  • The impact of the human papillomavirus vaccine on women's health: a systematic review [2024]

• Frontiers in Immunology
  • Current status and future directions for the development of human papillomavirus vaccines [2024]

• Frontiers in Public Health
  • Optimizing HPV vaccine effectiveness: impact of vaccination age and dose schedule on immunogenicity and cervical cancer prevention [2025]
  • Gender-neutral vs. gender-specific strategies in school-based HPV vaccination programs: a systematic review and meta-analysis [2025]

• Human Vaccines & Immunotherapeutics
  • Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review [2025]
  • Healthcare worker practices for HPV vaccine recommendation: A systematic review and meta-analysis [2024]
  • A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs [2024]

• International Federation of Gynecology and Obstetrics
  • FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV [2023]
  • Safety of HPV vaccination: a FIGO statement [2013]

• International Journal of Infectious Diseases
  • Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis [2025]

• International Journal of STD & AIDS
  • A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries [2023]

• International Papillomavirus Society
  • IPVS statement on “Temporary HPV vaccine shortage: Implications globally to achieve equity” [2020]

• Jornal de Pediatria
  • Cultural barriers and facilitators of the parents for human papillomavirus (HPV) vaccination uptake by their daughters: A systematic review [2025]

• Journal of Medical Internet Research
  • Effects of Message Framing on Human Papillomavirus Vaccination: Systematic Review [2024]

• Journal of the National Cancer Institute. Monographs
  • Human papillomavirus prophylactic vaccines: update on new vaccine development and implications for single-dose policy [2024]

• Lancet Public Health
  • Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis [2021]

• Medical Decision Making
  • Methodological Approaches for Incorporating Marginalized Populations into HPV Vaccine Modeling: A Systematic Review [2025]

• Medical Science Monitor
  • Global Guidelines and Trends in HPV Vaccination for Cervical Cancer Prevention [2025]

• Medicina
  • The Effectiveness of Interventions Targeting Adolescents in HPV Vaccination-A Scoping Review [2024]

• PLoS ONE
  • Perspectives of HPV vaccine decision-making among young adults: A qualitative systematic review and evidence synthesis [2025]

• Preventive Medicine Reports
  • Cost and effectiveness of HPV vaccine delivery strategies: A systematic review [2022]

• Viruses
  • Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology [2024]

Iran

• Intervirology
  • Type-Specific Human Papillomavirus Prevalence in Iranian Women with Normal Cervical Cytology: The Impact of Current HPV Vaccines [2017]

Ireland

• Health Information and Quality Authority
  • Human Papillomavirus

• Ireland's Health Services
  • HPV

• Royal College of Physicians of Ireland
  • Updated recommendations for HPV vaccination [2022]

Islamic countries

• PLoS ONE
  • Religious beliefs and practices toward HPV vaccine acceptance in Islamic countries: A scoping review [2024]

Israel

• Journal of Lower Genital Tract Disease
  • Impact of COVID-19 Pandemic on Human Papillomavirus Vaccine Uptake in Israel [2023]

Italy

• Human Vaccines & Immunotherapeutics
  • A cost-effectiveness analysis of adult human papillomavirus vaccination strategies in Italy [2025]

Jamaica

• Ministry of Health and Wellness Jamaica
  • Human Papillomavirus (HPV) Vaccine Information

Japan

• Cancer Science
  • Human papillomavirus vaccine to prevent CIN3 or worse (CIN3+): A nationwide case-control study in Japan [2025]
  • Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered [2024]
  • Disparities among Japanese municipalities in recommendations for routine and catch-up HPV vaccinations [2023]
  • A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan [2021]
  • Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program [2019]

• Health Promotion International
  • Evaluating the understandability and actionability of Japanese human papillomavirus vaccination educational materials on cervical cancer [2025]

• Human Vaccines & Immunotherapeutics
  • The effects of human papillomavirus vaccination in Japan [2025]
  • A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation [2023]
  • Changing trends in HPV vaccination in Japan [2022]
  • Health consciousness and cervical cancer screening rates in HPV-unvaccinated girls: comparison from HPV-recommended and HPV-recommendation-suspended program periods [2021]

• Lancet Regional Health – Western Pacific
  • The looming health hazard: A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine [2021]
  • Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data [2021]

• Scientific Reports
  • Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine [2020]
  • Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year [2018]

• Vaccine
  • Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis [2022]

• Vaccines
  • Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program [2022]

Kenya

• EClinicalMedicine
  • Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence [2022]

Latin America and the Caribbean

• Pan American Health Organization
  • Evaluating the impact of the human papillomavirus vaccine in Latin America and the Caribbean [2023]

Lebanon

• BMC Pediatrics
  • Human papillomavirus vaccine knowledge and conspiracy beliefs among secondary school students in Lebanon [2023]

Low and middle income countries

• BMC Health Services Research
  • Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014 [2016]

• BMJ Global Health
  • Human papillomavirus vaccine coverage surveys in low- and middle-income countries: current efforts and future considerations for very young adolescents [2025]

• Human Vaccines & Immunotherapeutics
  • Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives [2022]

• JNCI Cancer Spectrum
  • Human Papillomavirus Vaccination After COVID-19 [2021]

• Jornal de Pediatria
  • HPV vaccination programs in LMIC: is it time to optimize schedules and recommendations? [2023]

• Public Health
  • Features of human papillomavirus vaccination education strategies in low- and middle-income countries: a scoping review [2022]

• Vaccine
  • Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review [2022]
  • Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects [2013]

Luxembourg

• Cancer Epidemiology
  • Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg [2019]

Malaysia

• BMC Public Health
  • Cost- effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia [2016]

• Frontiers in Public Health
  • The impact of the COVID-19 pandemic on the national HPV immunization program in Malaysia [2022]

• Malaysian Society of Infectious Diseases & Chemotherapy
  • Human Papillomavirus

Middle East

• Epidemiology & Infection
  • Awareness and acceptance of human papillomavirus vaccine in the Middle East: A systematic review, meta-analysis, and meta-regression of 159 studies [2024]

Middle East, North Africa

• Eastern Mediterranean Health Journal
  • Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review [2018]

Morocco

• Pan African Medical Journal
  • Human papillomavirus vaccination in view of the National Cancer Control Plan 2020-2029 in Morocco [2023]

Netherlands

• BMC Medicine
  • The indirect effect of the bivalent human papillomavirus vaccination program: an observational cohort study [2025]
  • Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands [2025]

• Expert Review of Vaccines
  • Cost-effectiveness of nonavalent HPV vaccination in the Netherlands [2024]

• Health Council of the Netherlands
  • Change to HPV vaccine doses [2022]

• International Journal of Cancer
  • Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer [2021]

• Journal of Infectious Diseases
  • Changes in Genital Human Papillomavirus (HPV) Prevalence During 12 Years of Girls-Only Bivalent HPV Vaccination: Results From a Biennial Repeated Cross-sectional Study [2025]

New Zealand

• Health New Zealand
  • Human papillomavirus

• Immunisation Advisory Centre
  • Human papillomavirus (HPV)

• New Zealand Herpes Foundation
  • HPV Vaccine [2024]

Nigeria

• BMC Health Services Research
  • Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage [2017]

Nordic countries

• European Journal of Epidemiology
  • Infectious disease hospitalization after receipt of human papillomavirus vaccine: a nationwide register-based cohort study among Danish, Finnish, Norwegian, and Swedish girls [2025]

Norway

• BMC Public Health
  • Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway [2021]

• PLoS ONE
  • Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys [2014]

• Preventive Medicine
  • Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents [2015]

Peru

• PLoS ONE
  • Parental Acceptance of HPV Vaccine in Peru: A Decision Framework [2012]

Philippines

• BMC Public Health
  • A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines [2015]

• Cost Effectiveness and Resource Allocation
  • Incorporating economies of scale in the cost estimation in economic evaluation of PCV and HPV vaccination programmes in the Philippines: a game changer? [2018]

• Vaccine
  • The cost-effectiveness of human papillomavirus vaccination in the Philippines [2022]

Poland

• Ginekologia Polska
  • Cost-effectiveness of nonavalent vs bivalent HPV vaccine in Polish setting [2025]
  • Recommendations of the Polish Society of Gynaecologists and Obstetricians, Polish Paediatric Society, Polish Society of Family Medicine, Polish Society of Vaccinology, Polish Society of Oncological Gynaecology and Polish Society of Colposcopy and Pathophysiology of the Uterine Cervix on prophylactic vaccinations against infections with human papillomaviruses in Poland [2023]

Republic of Korea

• International Journal of Environmental Research and Public Health
  • Factors Associated with the HPV Vaccination among Korean Americans and Koreans: A Systematic Review [2021]

• Investigative and Clinical Urology
  • 2023 Korean sexually transmitted infections guidelines by the Korean Association of Urogenital Tract Infection and Inflammation: Human papillomavirus vaccination [2024]

• Journal of Gynecologic Oncology
  • Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines [2021]
  • Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline [2019]
  • Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline [2016]

• Virology Journal
  • Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study [2021]

Saudi Arabia

• Frontiers in Oncology
  • HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and Vaccination [2014]

• Frontiers in Public Health
  • Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescent females across Saudi Arabia [2025]

Scandinavian countries

• Journal of Infectious Diseases
  • Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries [2025]

Senegal

• Vaccine
  • National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned [2022]
  • Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal [2022]

Serbia

• PLoS ONE
  • Strengthening the role of community pharmacy in HPV vaccination roll-out in Serbia at national and local levels: A pharmacy-based education approach [2025]

Singapore

• Society for Colposcopy and Cervical Pathology of Singapore
  • SCCPS Scientific Committee Position Paper on HPV Vaccination [2020]

South Africa

• BMC Infectious Diseases
  • Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence [2015]

• Clinical Drug Investigation
  • Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa [2022]

South Asia

• Frontiers in Public Health
  • Uptake and determinants of HPV vaccination in South Asia: a systematic review and meta-analysis [2024]

Spain

• EuroSurveillance
  • Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016 [2019]

• Human Vaccines & Immunotherapeutics
  • Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain [2022]

Sub-Saharan Africa

• BMC Public Health
  • Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review [2023]

• BMJ Open
  • Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis [2023]

• Human Vaccines & Immunotherapeutics
  • Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis [2024]
  • Human papillomavirus vaccination coverage among young women in the three sub-Saharan African countries using Demographic and Health Surveys data [2024]

• PLoS ONE
  • Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review [2014]

Sweden

• American Journal of Epidemiology
  • Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs [2021]

• Archives of Gynecology and Obstetrics
  • Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008–2018, and perspectives on cancer prevention [2021]

• British Journal of Cancer
  • Impact of HPV vaccination on cervical screening performance: a population-based cohort study [2020]

• New England Journal of Medicine
  • HPV Vaccination and the Risk of Invasive Cervical Cancer [2020]

Switzerland

• BMC Infectious Diseases
  • Impact of HPV vaccination with Gardasil® in Switzerland [2017]

• BMC Public Health
  • Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland [2020]

• BMJ Open
  • Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study [2022]

Taiwan

• Journal of Microbiology, Immunology and Infection
  • Recommendations and guidance for human papillomavirus (HPV) vaccination for adults in Taiwan [2025]

• Taiwanese Journal of Obstetrics and Gynecology
  • Cervical cancer: Part I human papilloma virus vaccination in Taiwan [2024]

Tanzania

• Health Policy and Planning
  • Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania [2016]

• Vaccine
  • Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019 [2022]
  • National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation [2022]
  • Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania's national HPV vaccine introduction [2022]

Thailand

• Human Vaccines & Immunotherapeutics
  • Effectiveness of HPV vaccine as part of national immunization program for preventing HPV infection in Thai schoolgirls after seven years post-vaccination [2024]

• Journal of Gynecologic Oncology
  • Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting [2024]

• PLoS ONE
  • The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand [2021]

Togo

• Vaccine
  • Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo [2022]

Tunisia

• BMJ Open
  • Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling study [2024]

Uganda

• Infectious Agents and Cancer
  • Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review [2011]

• Vaccine
  • Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country [2018]

United Kingdom

• BMC Infectious Diseases
  • Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK [2019]

• BMJ
  • Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study [2024]
  • Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study [2019]

• HSC Public Health Agency
  • Human papillomavirus (HPV) immunisation programme - Factsheet for healthcare professionals [2023]

• Human Vaccines & Immunotherapeutics
  • Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom [2015]

• JAMA Network Open
  • Cost-Effectiveness of 9-Valent HPV Vaccination for Patients Treated for High-Grade Cervical Intraepithelial Neoplasia in the UK [2024]

• Lancet Regional Health - Europe
  • Association between HPV vaccination and cervical screening policy changes and cervical cancer incidence and grade-3 cervical intraepithelial neoplasia incidence in England, 2006-2020: a population-based trends analysis [2024]

• PLoS ONE
  • HPV Serology Testing Confirms High HPV Immunisation Coverage in England [2016]

• Public Health Scotland
  • HPV immunisation statistics Scotland
  • HPV education pack

• UK Health Security Agency
  • Human papillomavirus (HPV): the green book, chapter 18a
  • HPV vaccination programme
  • Adolescent vaccination programme in secondary schools for 2024 to 2025

• Vaccine
  • Risk of spontaneous abortion and other pregnancy outcomes in 15–25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom [2015]

United States

• Academic Pediatrics
  • Recommending Human Papillomavirus Vaccination at Age 9: A National Survey of Primary Care Professionals [2022]

• American Academy of Pediatrics
  • Why AAP recommends initiating HPV vaccination as early as age 9 [2019]

• American Cancer Society
  • Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation [2020]
  • HPV Vaccines
  • Guidelines for Human Papillomavirus Vaccine Use

• American College of Obstetricians and Gynecologists
  • Adjuvant Human Papillomavirus Vaccination for Patients Undergoing Treatment for Cervical Intraepithelial Neoplasia 2+ [2023]
  • Human Papillomavirus Vaccination [2020]

• American Society for Colposcopy and Cervical Pathology
  • ASCCP Committee Opinion: Adjuvant Human Papillomavirus Vaccine for Patients Undergoing Treatment for Cervical Intraepithelial Neoplasia [2023]

• American Society of Clinical Oncology
  • Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline [2017]
  • American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention [2016]

• BMC Pediatrics
  • Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008–2012 [2017]

• CA: A Cancer Journal for Clinicians
  • Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review [2022]

• Cancer Causes and Control
  • Lower human papillomavirus vaccine initiation and completion among Asian American adolescents compared to their peers: National Health and Nutritional Examination Survey 2011-2018 [2023]

• Cancer Epidemiology Biomarkers & Prevention
  • Disparities in healthcare providers’ recommendation of HPV vaccination for US adolescents: A systematic review [2021]
  • Assessing Impact of HPV Vaccination on Cervical Cancer Incidence in Women 15–29 years in the United States, 1999–2017: An Ecologic Study [2021]

• Cancer Medicine
  • An Ecological Analysis of HPV Vaccination in the United States Before and During the COVID-19 Pandemic by Age, Sex, and Urbanicity Using Private Insurance Claims Data [2025]

• Centers for Disease Control and Prevention
  • Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022 [2025]
  • Human Papillomavirus (HPV) Infection - STI Treatment Guidelines [2021]
  • Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018 [2021]
  • Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices [2019]
  • Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices [2016]
  • Human Papillomavirus (HPV) Vaccine Safety
  • HPV Vaccination: For Providers

• Food and Drug Administration
  • Gardasil

• Frontiers in Oncology
  • Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination [2016]

• Human Vaccines & Immunotherapeutics
  • Human papillomavirus vaccination at age 9 or 10 years to increase coverage - a narrative review of the literature, United States 2014-2024 [2025]
  • High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018 [2024]
  • Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities [2023]
  • Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020 [2023]
  • How to make effective HPV vaccine recommendations starting at age 9 [2023]
  • HPV vaccine recommendations by age: A survey of providers in federally qualified health centers [2023]
  • Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10 [2023]
  • Evidence supporting the initiation of HPV vaccination starting at age 9: Collection overview [2023]
  • Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen [2023]
  • Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9 [2022]
  • The influence of parent-child gender on intentions to refuse HPV vaccination due to safety concerns/side effects, National Immunization Survey - Teen, 2010-2019 [2022]
  • Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13–17 by metropolitan statistical area (MSA) status, National Immunization Survey – Teen, 2013 – 2017 [2020]
  • Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature [2019]
  • Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule [2015]

• International Journal of Cancer
  • Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening [2020]

• JAMA Health Forum
  • Prevalence of Human Papillomavirus Infection Among Women Born in the 1990s vs the 1980s and Association With HPV Vaccination in the US [2022]
  • Human Papillomavirus Vaccine Administration Trends Among Commercially Insured US Adults Aged 27-45 Years Before and After Advisory Committee on Immunization Practices Recommendation Change, 2007-2020 [2022]

• JAMA Network Open
  • Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017 [2022]
  • Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women [2019]

• JAMA Pediatrics
  • Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US [2022]

• Journal of Adolescent Health
  • Getting Human Papillomavirus Vaccination Back on Track: A National Survey [2023]
  • Levels of Parental Human Papillomavirus Vaccine Hesitancy and Their Reasons for Not Intending to Vaccinate: Insights From the 2019 National Immunization Survey-Teen [2022]

• Journal of Immigrant and Minority Health
  • Nativity Differences in Awareness and Knowledge About HPV Infection and Vaccination Among U.S. Adults: Findings from a National Population-Based Sample [2022]

• National Cancer Institute
  • Human Papillomavirus (HPV) Vaccines
  • HPV Vaccination

• Preventive Medicine Reports
  • Obstetrician/gynecologists’ HPV vaccination recommendations among women and girls 26 and younger [2022]
  • Association between patient characteristics and HPV vaccination recommendation for postpartum patients: A national survey of Obstetrician/Gynecologists [2022]

• StatPearls
  • Human Papilloma Virus Vaccine

• Vaccine
  • Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis [2021]
  • Regional variations in human papillomavirus prevalence across time in NHANES (2003–2014) [2019]
  • Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers [2014]

• Vaccines
  • Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019–2020 [2022]

WHO

• International Agency for Research on Cancer
  • Protection from a Single Dose of HPV Vaccine [2023]

• World Health Organization
  • WHO preferred product characteristics for therapeutic HPV vaccines [2024]
  • Considerations for human papillomavirus (HPV) vaccine product choice, second edition [2024]
  • Considerations for human papillomavirus (HPV) vaccine product choice [2024]
  • User manual for WHO cervical cancer prevention and control costing tool: HPV vaccination module (C4P-HPV tool) [2023]
  • Human papillomavirus vaccines: WHO position paper, December 2022 [2022]
  • Global market study: HPV vaccines [2022]
  • Human papillomavirus (HPV) vaccine coverage monitoring manual [2020]
  • HPV Vaccine Coverage Monitoring Manual [2020]
  • Scaling-up HPV vaccine introduction [2016]
  • HPV vaccine communication: special considerations for a unique vaccine. 2016 update [2016]
  • Guide to introducing HPV vaccine into national immunization programmes [2016]
  • The immunological basis for immunization series: module 19: human papillomavirus infection [2011]
  • Report of the meeting on HPV vaccine coverage and impact monitoring, 16-17 November 2009, Geneva, Switzerland [2010]
  • Cervical cancer, human papillomavirus (HPV) and HPV vaccines : key points for policy-makers and health professionals [2007]
  • Preparing for the introduction of HPV vaccines : policy and programme guidance for countries [2006]
  • Immunizing against HPV
  • Human papillomavirus vaccines (HPV)
  • HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%)

WHO Western Pacific Region

• Vaccines
  • A Review of the Implementation Status of and National Plans on HPV Vaccination in 17 Middle-Income Countries of the WHO Western Pacific Region [2021]

Zimbabwe

• Asian Pacific Journal of Cancer Prevention
  • Behavioural and Social Drivers (BeSD) of HPV vaccination in Zimbabwe: A Rapid Scoping Review of Literature [2025]

• Infectious Agents and Cancer
  • Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe [2014]

• Vaccine
  • HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls [2022]

{Related topics}

• Topic
  • Genital warts, HPV vaccine for men
  • Cervical cancer: screening, prevention
  • Cervical cancer